Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Babafemi Taiwo David M. Margolis |
| Publication date | September 11, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |